PROCEPT BioRobotics Sees Q1 Sales $79.000M-$82.000M vs $92.646M Est
Benzinga Newsdesk 8 months ago
NewsGuidance
PROCEPT BioRobotics (NASDAQ:PRCT) sees Q1 sales of $79.000 million-$82.000 million vs $92.646 million analyst estimate.
PROCEPT BioRobotics (NASDAQ:PRCT) sees Q1 sales of $79.000 million-$82.000 million vs $92.646 million analyst estimate.